VIP Spray 10mg is a research-grade intranasal peptide formulation developed to support laboratory investigations involving Vasoactive Intestinal Peptide (VIP), neuropeptide biology, GPCR signaling, molecular pharmacology, peptide chemistry, intracellular communication, formulation science, and neuroscience research. VIP is a naturally occurring 28-amino acid neuropeptide widely distributed throughout the central and peripheral nervous systems as well as numerous peripheral tissues. Because of its broad receptor distribution and well-characterized signaling mechanisms, VIP remains one of the most extensively investigated endogenous neuropeptides in molecular biology research. The standardized intranasal spray formulation enables researchers to investigate peptide stability, receptor interactions, analytical reproducibility, and formulation characteristics under controlled laboratory conditions.
A primary area of VIP research focuses on its interaction with VPAC1 and VPAC2 receptors, both members of the G protein-coupled receptor (GPCR) family. Researchers investigate receptor activation, ligand binding, intracellular signaling, receptor selectivity, and downstream molecular responses to better understand peptide-mediated communication within experimental systems. These investigations contribute to broader scientific understanding of GPCR biology while remaining exclusively within Research Use Only laboratory applications.
Scientific investigations also examine VIP in relation to intracellular signaling pathways involving adenylate cyclase, cyclic AMP (cAMP), protein kinase A (PKA), CREB activation, ERK/MAPK signaling, and peptide-mediated molecular communication. Researchers continue evaluating these interconnected pathways to better characterize intracellular regulatory mechanisms and neuropeptide pharmacology in laboratory models.
The intranasal spray formulation provides additional scientific value by allowing laboratories to investigate formulation stability, spray consistency, peptide integrity, physicochemical characteristics, analytical reproducibility, and intranasal delivery system performance. Comparative laboratory investigations frequently evaluate spray formulations alongside lyophilized peptide preparations to better understand formulation behavior, stability profiles, analytical characteristics, and standardized laboratory handling procedures.
VIP Spray is commonly investigated alongside PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide), Oxytocin, DSIP, Semax, Selank, and additional neuroactive investigational peptides. Comparative laboratory studies evaluate receptor interactions, intracellular signaling pathways, molecular stability, analytical chemistry, formulation science, and peptide pharmacology to better understand similarities and distinctions among neuropeptide signaling systems.
The 10mg formulation is particularly valuable for laboratories conducting GPCR biology investigations, receptor signaling studies, formulation comparison research, peptide characterization, analytical validation, molecular pharmacology investigations, biomarker discovery, and neuroscience experiments requiring standardized intranasal investigational materials.
Beyond neuroscience investigations, VIP Spray serves as an important analytical reference material within peptide chemistry, molecular biology, analytical chemistry, pharmaceutical analysis, proteomics, biochemistry, formulation science, drug delivery research, cell biology, and systems biology. The expanding scientific literature surrounding VIP provides researchers with valuable investigational material for analytical method development, formulation comparison studies, laboratory quality assurance, and peptide stability investigations.
Each batch of VIP Spray 10mg is manufactured according to stringent research-grade production standards and undergoes comprehensive analytical verification before release. Quality assurance procedures include peptide identity confirmation, analytical purity verification, formulation consistency evaluation, packaging inspection, microbial quality testing where appropriate, and batch-specific quality control documentation. These procedures support reproducibility, consistency, and confidence across independent laboratory investigations.
To preserve formulation quality, VIP Spray should be stored according to accepted laboratory recommendations for peptide formulations. Appropriate storage conditions, controlled laboratory handling, and adherence to institutional protocols help maintain formulation integrity before analytical evaluation and experimental use.
Although VIP continues to receive significant scientific attention, research involving VPAC receptor biology, GPCR signaling, cAMP-mediated intracellular communication, neuropeptide regulation, and intranasal peptide formulation science remains active and continues to evolve. Accordingly, VIP Spray 10mg should be regarded exclusively as an investigational laboratory material intended to support scientific discovery and analytical research.
VIP Spray 10mg is supplied exclusively for laboratory research and analytical applications. This product is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary applications, cosmetic use, or diagnostic purposes.
